Sign up for the Race/Related Newsletter join a deep and provocative exploration of race identity and society with New York Times journalists. Get it sent to your inbox.
At meeting held on 01 June 2022
The Board of Concord Drugs at its meeting held on 01 June 2022 has approved appointment of K Sumeela as an Additional Director of the company with effect from 01 June 2022. The Board also approved the resignation of P Chandrakala as Independent Director of the company with effect from 01 June 2022.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
